Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ultra-Low-Flow Sevoflurane Anesthesia on Carbon Footprint and Cost: A Randomized Controlled Study in Cardiac Surgery Patients

NCT07313969 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.

NCT NCT07313969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07313969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ultra-Low-Flow Sevoflurane Anesthesia on Carbon Footprint and Cost: A Randomized Controlled Study in Cardiac Surgery Patients
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2025
Completion date
May 15, 2026
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, low flow anesthesia, sevoflurane anesthesia